Harmony Biosciences Files Q1 2025 10-Q
Ticker: HRMY · Form: 10-Q · Filed: May 6, 2025 · CIK: 1802665
| Field | Detail |
|---|---|
| Company | Harmony Biosciences Holdings, INC. (HRMY) |
| Form Type | 10-Q |
| Filed Date | May 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Harmony Biosciences Q1 2025 10-Q is in. Check financials.
AI Summary
Harmony Biosciences Holdings, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported financial results and provided updates on its business operations. Key financial figures and operational details are included in the filing.
Why It Matters
This filing provides investors with the latest financial performance and operational status of Harmony Biosciences, crucial for understanding the company's trajectory and making informed investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Harmony Biosciences faces inherent risks related to drug development, regulatory approvals, and market competition, which are detailed in its SEC filings.
Key Numbers
- 20250331 — Reporting Period End Date (Indicates the end of the fiscal quarter for which financial information is reported.)
- 20250506 — Filing Date (The date the 10-Q report was officially submitted to the SEC.)
Key Players & Entities
- Harmony Biosciences Holdings, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250506 (date) — Filing date
- 0001802665 (company) — Central Index Key for Harmony Biosciences Holdings, Inc.
FAQ
What is the primary business of Harmony Biosciences Holdings, Inc.?
Harmony Biosciences Holdings, Inc. operates in the Pharmaceutical Preparations industry, as indicated by its Standard Industrial Classification code [2834].
What is the fiscal year end for Harmony Biosciences Holdings, Inc.?
The fiscal year end for Harmony Biosciences Holdings, Inc. is December 31 (1231).
What is the SEC file number for Harmony Biosciences Holdings, Inc.?
The SEC file number for Harmony Biosciences Holdings, Inc. is 001-39450.
What is the address of Harmony Biosciences Holdings, Inc.?
The business and mail address for Harmony Biosciences Holdings, Inc. is 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA 19462.
What is the accession number for this 10-Q filing?
The accession number for this 10-Q filing is 0001558370-25-006394.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 6, 2025 regarding Harmony Biosciences Holdings, Inc. (HRMY).